主页 > 医学文档 >
【每日动态】每日生物医药动态报道
新的诱导干细胞可能在最初阶段显示癌症苗头
New induced stem cells may unmask cancer at earliest stage
http://www.eurekalert.org/pub_releases/2011-02/uow-nis020311.php
儿童BMI随母亲工作年度增加而提高
Children's BMI found to rise the longer their mothers work
http://www.eurekalert.org/pub_releases/2011-02/sfri-cbf012711.php
增加患者的免疫反应,也许对治疗HIV起关键作用
Boosting body's immune response may hold key to HIV cure
http://www.eurekalert.org/pub_releases/2011-02/waeh-bbi020211.php
普林斯顿科学家发现乳腺癌转移至骨头的机制
Princeton scientists discover mechanism involved in breast cancer's spread to bone
http://www.eurekalert.org/pub_releases/2011-02/pu-psd020211.php
Scripps 研究所科学家发现很有效的蛋白稳定技术方法
Scripps Research scientists develop powerful new methodology for stabilizing proteins
http://www.eurekalert.org/pub_releases/2011-02/sri-srs020211.php
冷泉港实验室科学家发现皮肤癌干细胞起源,和癌变的遗传学根基
CSHL study unmasks a stem cell origin of skin cancer and the genetic roots of malignancy
http://www.eurekalert.org/pub_releases/2011-02/cshl-csu020111.php
自1080年以来,肥胖症已经翻倍,全球研究分析揭示其风险因素
Obesity has doubled since 1980, major global analysis of risk factors reveals
http://www.eurekalert.org/pub_releases/2011-02/icl-ohd020111.php
治疗前列腺癌的新窍门
http://online.wsj.com/article/SB10001424052748703960804576120194229203936.html?mg=com-wsj&mod=dist_smartbrief
葛兰素CEO强调他的公司将继续在英国大力投资
http://www.fiercebiotech.com/story/gsks-witty-were-committed-britain/2011-02-04
Get Ready for Merck's Bumpy Ride
Motley Fool Thu, 02/03/11 - 7:47 pm
tags: Merck
Merck CEO To Wall Street: Who Needs Guidance?
Pharmalot Thu, 02/03/11 - 6:15 pm
tags: guidance, Kenneth Frazier, Merck, Pharma CEOs
Health Care Reform Cuts Into Sales: Glaxo CEO
CNBC Thu, 02/03/11 - 6:13 pm
tags: Andrew Witty, earnings, GSK, healthcare reform
Legal costs behind Merck, GlaxoSmithKline losses in 4Q
Bizjournals.com Thu, 02/03/11 - 6:12 pm
tags: earnings, GSK, legal, Merck
FDA Rejection Would Take Isis Stock Down
Seeking Alpha Thu, 02/03/11 - 11:47 am
tags: Contrave, FDA, Isis, mipomersen, Orexigen
Novo Nordisk Passes This Key Test
Motley Fool Thu, 02/03/11 - 11:17 am
tags: Novo Nordisk
Allergan - Upgrades & Downgrades
TheStreet.com Thu, 02/03/11 - 11:16 am
tags: Allergan
Optimer Gets NEJM Power
Forbes Thu, 02/03/11 - 11:10 am
tags: Clostridium Difficile, Fidaxomicin, New England Journal of Medicine, Optimer
辉瑞新的收购目标
Pfizer's Newest Acquisition Target
Motley Fool Thu, 02/03/11 - 10:33 am
tags: Amarin, Clinical Data, Dendreon, M&A, Pfizer
葛兰素第四季度因为文迪雅拖累而亏损
Glaxo posts Q4 loss on Avandia charge
Yahoo/AP Thu, 02/03/11 - 10:31 am
tags: earnings, GSK
Takeda Says Nine-Month Profit Falls on Prevacid, Yen
Bloomberg Thu, 02/03/11 - 10:10 am
tags: earnings, Takeda
Pfizer Geysers
WSJ Online Thu, 02/03/11 - 10:09 am
tags: Pfizer
默克第四季度亏损
Merck swings to a fourth-quarter loss
Marketwatch Thu, 02/03/11 - 10:08 am
tags: earnings, Merck
2011年五大重大突破新药
5 Breakthrough Drugs for 2011
Barron's Thu, 02/03/11 - 10:06 am
tags: Bayer, Benlysta, Bristol-Myers Squibb, GSK, Human Genome Sciences, INCB-18424, Incyte, ipilimumab, J&J, Novartis,
Telaprevir, Vertex, Xarelto Novo Confirms Potential in New Insulin but Challenges Remain
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-02-06 12:23
医学,生命科学网